Assistant Professor, Medicine, Case Western Reserve Univ Sch of Med
Pulmonology
Dr. Omar A. Minai, MD
|
|
Give Review
Omar Minai works in the field of Pulmonology. He attended Aga Khan Medical College. He received awards:"CMS Meaningful Use Stage 1 Certification". Omar Minai is also a published doctor. He has 80 publication published. The most recent publication is: Manifestations of scleroderma pulmonary disease. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
- Assessment Of Patient-Reported Health Status In Pulmonary Arterial Hypertension Patients Treated With Riociguat: 2-Year Results From The Patent-2 Extension Study.
- Assessment Of Patient-Reported Health Status In Chronic Thromboembolic Pulmonary Arterial Hypertension Patients Treated With Riociguat: 2-Year Results From The Chest-2...
- Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
- Association of impaired heart rate recovery with cardioPulmonary complications after lung cancer resection surgery.
- Heart rate slopes during 6-min walk test in Pulmonary arterial hypertension, other lung diseases, and healthy controls.
- Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension.
- Clinical characterization and survival of patients with borderline elevation in Pulmonary artery pressure.
- Value of Impedance Cardiography during 6-Minute Walk Test in Pulmonary Hypertension.
- Causes and Circumstances of Death in Pulmonary Arterial Hypertension.
- Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with Pulmonary hypertension.
- Impact of Pulmonary hemodynamics on 6-min walk test in idiopathic Pulmonary fibrosis.
- Prevalence and significance of decreased bone density in Pulmonary arterial hypertension.
- Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension.
- ABNORMAL PLATELET AGGREGATION IN IDIOPATHIC Pulmonary ARTERIAL HYPERTENSION: ROLE OF NITRIC OXIDE.
- Heart Rate Recovery Predicts Clinical Worsening in Patients with Pulmonary Arterial Hypertension.
- Sleep quality, depression, and quality of life in patients with Pulmonary hypertension.
- Pulmonary hypertension in COPD: epidemiology, significance, and management: Pulmonary vascular disease: the global perspective.
- Frequency and impact of Pulmonary hypertension in patients with obstructive sleep apnea syndrome.
- Bronchogenic carcinoma after Lung transplantation: characteristics and outcomes.
- BMPR2 mutation in a patient with Pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
- Inflammatory myofibroblastic tumor of the Lung: recurrence after steroid treatment.
- The evaluation and preparation of the patient for Lung volume reduction surgery.
- Comorbidities in Chronic obstructive pulmonary disease.
- Cardiac disease in Chronic obstructive pulmonary disease.
- Sleep abnormalities and treatment in Emphysema.
- Inhaled and systemic corticosteroids in Chronic obstructive pulmonary disease.
- Natural history of Emphysema.
- Overview of the perioperative management of Lung volume reduction surgery patients.
- Prevalence and characteristics of restless legs syndrome in patients with Pulmonary hypertension.
- Treating Pulmonary arterial hypertension: cautious hope in a deadly disease.
- Diagnostic strategies for suspected Pulmonary arterial hypertension: a primer for the internist.
- What risks does a history of Pulmonary hypertension present for patients undergoing noncardiac surgery?
- Long-term outcome in a patient with Pulmonary hypertension and hereditary hemorrhagic telangiectasia.
- Scedosporium apiospermum (Pseudoallescheria boydii) infection in Lung transplant recipients.
- A 45-year-old woman with Systemic lupus erythematosus and progressive dyspnea.
- Predictors of nocturnal oxygen desaturation in Pulmonary arterial hypertension.
- Restless legs syndrome in Lung transplant recipients.
- Acanthosis nigricans following single Lung transplantation: a case report.
- Lung transplantation in a patient with Mounier-Kuhn syndrome.
- Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan.
- A young man with unexplained dyspnea.
- Surgical intervention in patients with moderate to severe Pulmonary arterial hypertension.
- Auto-positive end-expiratory pressure: mechanisms and treatment.
- Race as an independent prognostic factor in patients with idiopathic Pulmonary arterial hypertension.
- Referral for Lung transplantation: a moving target.
- Reprocessing the bronchoscope: the challenges.
- Pulmonary nodules in lung transplant recipients: etiology and outcome.
- The role of self-expandable metallic stents for the treatment of airway complications after Lung transplantation.
- Implementing a shared-care approach to improve the management of patients with Pulmonary arterial hypertension.
- Treatments and strategies to optimize the comprehensive management of patients with Pulmonary arterial hypertension.
- Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of Lung transplants.
- Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns.
- Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery.
- A 60-year old man presenting with yellow nail syndrome.
- Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.
- Safety of diagnostic bronchoscopy in patients with Pulmonary hypertension.
- Vaso-active therapy can improve 6-min walk distance in patients with Pulmonary hypertension and fibrotic interstitial lung disease.
- Lung transplantation for idiopathic Pulmonary fibrosis.
- Long-term experience after transition from parenteral prostanoids to oral agents in patients with Pulmonary hypertension.
- Bosentan in Systemic sclerosis.
- The effect of lung volume reduction surgery on Chronic obstructive pulmonary disease exacerbations.
- Overview of treprostinil sodium for the treatment of Pulmonary arterial hypertension.
- Effect of lung volume reduction surgery on resting Pulmonary hemodynamics in severe emphysema.
- Lupus-associated Pulmonary hypertension: long-term response to vasoactive therapy.
- Estimating Pulmonary artery pressures by echocardiography in patients with emphysema.
- Therapy for alpha1-antitrypsin deficiency: pharmacology and clinical recommendations.
- Hernia of the Lung: a case report and review of literature.
- Manifestations of scleroderma Pulmonary disease.
- Infection control in the bronchoscopy suite. A review.
- Utility of transbronchial needle aspiration in the diagnosis of endobronchial lesions.
- Comorbidities in end-stage Lung disease.
- Role of Tc-99m MIBI in the evaluation of single Pulmonary nodules: a preliminary report.
- A 72-year-old smoker with interstitial Lung disease.
- Pulmonary involvement in Niemann-Pick disease: case report and literature review.
- A Lung-transplant recipient with infiltrates.
- Coccidioidomycosis in non-endemic areas: a case series.
- Pulmonary hypertension in polymyositis-dermatomyositis: clinical and hemodynamic characteristics and response to vasoactive therapy.
- Challenges in the diagnosis and management of Nocardia infections in Lung transplant recipients.
Schools
Aga Khan Medical College The Aga Khan University
University Conn
Cleve Clin Found
Procedures Preformed
- Bronchoscopy
- Continuous Positive Airway Pressure (CPAP)
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acute Pharyngitis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Sleep Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Cleveland Clinic Foundation -
Mount Sinai Hospital -
Aga Khan Medical College
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1508820986 | |
| NPPES Provider LastName | MINAI | |
| NPPES Provider FirstName | OMAR | |
| NPPES Provider ZIPCode | 238602621 | |
| NPPES Provider State | VA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 1033.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508820986 |
| Last Name Of The Provider | MINAI |
| First Name Of The Provider | OMAR |
| View All |
Similar Doctors
|
Dr. Mariana C. Petrozzi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yaser Abu El-Sameed, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jonathan Z. Baskin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica L. Vensel Rundo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brian B. Koo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Harneet K. Walia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sally Ibrahim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhu Sasidhar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Somnath Bose, MD |